Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.
March 4, 2008
ZAGREB, Croatia—Milsing d.o.o. announced new distribution agreements in Italy and Austria to expand the availability of its Lectranal® specialty ingredient. Sochim is now distributing Lectranal in Italy; the manufacturer Pharmasuisse has already picked up the ingredient and launched a finished product, Reactyl®. In Austria, Kosan Pharma is Milsing’s exclusive distributor, working to prepare a marketing strategy and ensuring compliance with Austrian regulatory requirements.According to the company, Lectranal is a patent-pending blend of Astragalus membranaceous extract and a mineral carrier, designed to regulate the immune system and relieve allergy symptoms. Milsing also released results of a double blind, placebo-controlled study, showing the ingredient was superior to placebo in improving quality of life and intensity of symptoms among patients with allergic rhinitis.
You May Also Like
Dr. Mercola allegedly plans to introduce psychic advisor to followersMar 1, 2024
The Vitamin Shoppe general counsel criticizes NY age-restriction lawMar 1, 2024
Is kratom a safe life-giver or a dangerous life-taker?Mar 1, 2024
Patents can offer supplement brands competitive advantageMar 1, 2024